Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of...

83
S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMS n , 2D-NMR and FTIR Ch Krishnam Raju 1,2 , J V Shanmukha Kumar* 1 , Sanath Kumar Goud 2 1 Department of chemistry,K L University, Guntur, Andhra Pradesh-522502, India. 2 Analytical Research and Development, United States Pharmacopeial Convention – India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad, Telangana-500078, India. List of figures: 1. HPLC chromatogram ofCIL degradation products S-6 2. UPLC chromatogram of mixed sample solution of CIL with degradants S-7 3. Final purity of CD1 S-8 4. Final purity of CD2 S-8 5. Final purity of CD3 S-9 6. Chiral purity of CIL S-9 7. High resolution mass spectrum of CIL S-10 8. Mass accuracy of CIL S-11 Electronic Supplementary Material (ESI) for New Journal of Chemistry. This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2017

Transcript of Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of...

Page 1: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-1

Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn,

2D-NMR and FTIR

Ch Krishnam Raju1,2 , J V Shanmukha Kumar*1, Sanath Kumar Goud2

1Department of chemistry,K L University, Guntur, Andhra Pradesh-522502, India.

2Analytical Research and Development, United States Pharmacopeial Convention – India (P) Ltd., Plot No. D6 & D8, IKP, Genome

Valley, Shameerpet, Hyderabad, Telangana-500078, India.

List of figures:

1. HPLC chromatogram ofCIL degradation products S-6

2. UPLC chromatogram of mixed sample solution of CIL with degradants S-7

3. Final purity of CD1 S-8

4. Final purity of CD2 S-8

5. Final purity of CD3 S-9

6. Chiral purity of CIL S-9

7. High resolution mass spectrum of CIL S-10

8. Mass accuracy of CIL S-11

Electronic Supplementary Material (ESI) for New Journal of Chemistry.This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2017

Page 2: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-2

9. High resolution MSMS Spectrum of CIL S-12

10. MSnspectrum of CIL S-13

11. Mass fragmentation pathway of CIL S-14

12. High resolutionmass Spectrum of CD1 S-15

13. Mass accuracy of CD1 S-16

14. High resolutionMSMS Spectrum of CD1 S-17

15. MSn spectrum of CD1 (a) S-18

16. MSn spectrum of CD1 (b) S-19

17. Mass fragmentation pathway of CD1 S-20

18. High resolutionmass Spectrum of CD2 S-21

19. Mass accuracy of CD2 S-22

20. High resolutionMSMS Spectrum of CD2 S-23

21. MSn spectrum of CD2 (a) S-24

22. MSn spectrum of CD2 (b) S-25

23. Mass fragmentation pathway of CD2 S-26

24. High resolution mass Spectrum of CD3 S-27

25. Mass accuracy of CD3 S-28

26. High resolution MSMS Spectrum of CD3 S-29

Page 3: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-3

27. MSn spectrum of CD3 S-30

28. Mass fragmentation pathway of CD3 S-31

29. High resolution mass Spectrum of KD1 S-32

30. Mass accuracy of KD1 S-33

31. GCMS Spectrum of KD2 S-34

32. GCMS Library match spectrum for KD2 S-35

33. High resolution mass Spectrum of KD3 S-36

34. Mass accuracy of KD3 S-37

35. High resolution mass Spectrum of KD4 S-38

36. Mass accuracy of KD4 S-39

37. 1H NMR Spectrum of CD1 S-40

38. 13C NMR Spectrum of CD1 S-41

39. DEPT90 NMR Spectrum of CD1 S-42

40. DEPT135 NMR Spectrum of CD1 S-43

41. COSY NMR Spectrum of CD1 S-44

42. TOCSY NMR Spectrum of CD1 S-45

43. HSQC NMR Spectrum of CD1 S-46

44. HMBC NMR Spectrum of CD1 S-47

Page 4: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-4

45. NOESY NMR Spectrum of CD1 S-48

46. ROESY NMR Spectrum of CD1 S-49

47. ROESY NMR Zoomed Spectrum of CD1 S-50

48. 1H NMR Spectrum of CD2 S-51

49. 13C NMR Spectrum of CD2 S-52

50. DEPT90 NMR Spectrum of CD2 S-53

51. DEPT135 NMR Spectrum of CD2 S-54

52. COSY NMR Spectrum of CD2 S-55

53. TOCSY NMR Spectrum of CD2 S-56

54. HSQC NMR Spectrum of CD2 S-57

55. HMBC NMR Spectrum of CD2 S-58

56. NOESY NMR Spectrum of CD2 S-59

57. ROESY NMR Spectrum of CD2 S-60

58. ROESY NMR Zoomed Spectrum of CD2 S-61

59. 1H NMR Spectrum of CIL S-62

60. 13C NMR Spectrum of CIL S-63

61. DEPT90 NMR Spectrum of CIL S-64

62. DEPT135 NMR Spectrum of CIL S-65

Page 5: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-5

63. COSY NMR Spectrum of CIL S-66

64. TOCSY NMR Spectrum of CIL S-67

65. HSQC NMR Spectrum of CIL S-68

66. HMBC NMR Spectrum of CIL S-69

67. NOESY NMR Spectrum of CIL S-70

68. 1H NMR Spectrum of CD3 S-71

69. 13C NMR Spectrum of CD3 S-72

70. DEPT90 NMR Spectrum of CD3 S-73

71. DEPT135 NMR Spectrum of CD3 S-74

72. COSY NMR Spectrum of CD3 S-75

73. TOCSY NMR Spectrum of CD3 S-76

74. HSQC NMR Spectrum of CD3 S-77

75. HMBC NMR Spectrum of CD3 S-78

76. IR Spectrum of CD1 S-79

77. IR Spectrum of CD2 S-80

78. IR Spectrum of CD3 S-81

79. Prep HPLC chromatogram for the isolation of CD3 S-82

80. Prep HPLC chromatogram for the isolation of CD1 and CD2. S-83

Page 6: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-6

Figure 1: HPLC chromatograms Base degradation (a), Acid degradation (b), Photolytic degradation (c), Oxidative degradation (d),Heat degradation (e),Humid degradation (f)

Page 7: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-7

Figure2:UPLC chromatogram of mixed sample solution of CIL with degradants.

Page 8: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-8

Figure3:Final purity of CD1

Figure4:Final purity of CD2

Pea

k1 -

15.9

91

Pea

k2 -

17.4

30C

D-I

- 18.

221

Pea

k4 -

19.0

00P

eak5

- 19

.952

AU

-0.010

0.000

0.010

0.020

0.030

0.040

0.050

0.060

0.070

0.080

0.090

0.100

0.110

0.120

Minutes0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00 40.00 42.00 44.00

Pea

k1 -

13.3

70

Pea

k2 -

16.1

52

Pea

k3 -

18.1

90C

D-II

- 18

.979

Pea

k5 -

20.9

06P

eak6

- 21

.031

Pea

k7 -

22.0

67

AU

0.00

0.02

0.04

0.06

0.08

0.10

0.12

Minutes0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00 40.00 42.00 44.00

Page 9: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-9

Figure5:Final purity of CD3

Figure6: Chiral purity of CIL

CD

3 - 2

9.10

6P

eak2

- 30

.299

AU

0.00

0.02

0.04

0.06

0.08

0.10

0.12

0.14

0.16

0.18

0.20

Minutes0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00 40.00 42.00 44.00

CIL

-Isom

er-1

- 5.

404

CIL-

Isom

er-2

- 6.

370

AU

-0.10

0.00

0.10

0.20

0.30

0.40

0.50

0.60

0.70

0.80

0.90

1.00

1.10

1.20

1.30

1.40

1.50

Minutes0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00

Page 10: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-10

Figure7:High resolution mass spectrum of CIL

Page 11: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-11

Figure 8:Mass accuracy of CIL

Page 12: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-12

Figure9: High resolution MSMS Spectrum of CIL

Page 13: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-13

Figure 10: MSn spectrum of CIL

Page 14: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-14

H2N

O OO

OO

NO2C27H29N2O7

+, 493.1969Nitrogen rule: Even, RDBE: 14.5

CIL

C27H27N2O6+, 475.1864

Nitrogen rule: Even, RDBE: 15.5

N

O OO

O

NO2

-H2O

C9H9+, 117.0699

Nitrogen rule: Even, RDBE: 5.5

-C18H20N2O7

N

HOHO O

OO

NO2

C18H19N2O7+, 375.1187

Nitrogen rule: Even, RDBE: 10.5

-C9H10

N

HO OH2

OO

NO2

C15H13N2O6+, 317.0768

Nitrogen rule: Even, RDBE: 10.5

-C3 H

6 O

N

HO

O

NO2

C14H11N2O4+, 271.0713

Nitrogen rule: Even, RDBE: 10.5

-CH2 O

2

-C3H8O2

-C9H8

N

H2O

O

C14H12NO2+, 226.0863

Nitrogen rule: Odd, RDBE: 9.5

N

O

OO

NO

C24H21N2O5+, 417.1445

Nitrogen rule: Even, RDBE: 15.5

OH2

N

HO

OO

NOC15H13N2O5

+, 301.0819Nitrogen rule: Even, RDBE: 10.5

OH2

-CHN

O 4

HN

O

C14H12NO+, 210.0913Nitrogen rule: Odd, RDBE: 9.5

-C10H

8 NO4

N

HO

O

NO

C14H11N2O3+, 255.0764

Nitrogen rule: Even, RDBE: 10.5

-CH2 O

2

Figure 11: Mass fragmentation pathway of CIL

Page 15: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-15

Figure 12:High resolution mass spectrum of CD1

Page 16: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-16

Figure13: Mass accuracy of CD1

Page 17: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-17

Figure14:High resolution MSMS Spectrum of CD1

Page 18: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-18

Figure15:MSn Spectrum of CD1 (a)

Page 19: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-19

Figure16:MSn Spectrum of CD1 (b)

Page 20: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-20

C27H31N2O10+, 543.1973

Nitrogen rule: Even, RDBE: 13.5CD1

O O

O

O

O

O

O

NO2

NH2HO

C26H31N2O8+, 499.2075

Nitrogen rule: Even, RDBE: 12.5

O O

O

O

O

NO2

NH2HO

C26H29N2O6+, 465.2020

Nitrogen rule: Even, RDBE: 13.5

HO

O

O

NO2

HON

NH2

NO2

O

O

OO

OO

H

C18H21N2O8+, 393.1292

Nitrogen rule: Even, RDBE: 9.5

NH

NO2

OOH

OO

H

C17H21N2O6+, 349.1394

Nitrogen rule: Even, RDBE: 8.5

C23H21N2O4+, 389.1496

Nitrogen rule: Even, RDBE: 13.5

HO

O

NO2

N

C14H16NO+, 214.1226Nitrogen rule: Odd, RDBE: 7.5

H2O

N

N

C12H14N+, 172.1121Nitrogen rule: Odd, RDBE: 6.5

C12H11+, 155.0855

Nitrogen rule: Even, RDBE: 7.5

C26H30N2O7•+, 482.2048

Nitrogen rule: Even, RDBE: 13.0

O O

O

O

O

NO2

NH2

NH2

OO

H

C7H12NO2+, 142.0863

Nitrogen rule: Odd, RDBE: 1.5

HN

NO2

O

C15H17N2O3+, 273.1234

Nitrogen rule: Even, RDBE: 8.5

HN

NO2

C14H17N2O2+, 245.1285

Nitrogen rule: Even, RDBE: 7.5

C9H9+, 117.0699

Nitrogen rule: Even, RDBE: 5.5

-C18H22N2O10

-CO2

-H2O2

-OH.

-C 12H 13NO5

-C2H2O -C2H5NO

-C3H8O2

-C3 H

10O3

-C9H10O-C10H10O2

-C9H10O2

-CO2-C11H9NO6

-C2H4O3-C3H4O4

O

NO2

N

C14H11N2O4+, 271.0713

Nitrogen rule: Even, RDBE: 10.5

HO

NO2

N

C13H11N2O3+, 243.0764

Nitrogen rule: Even, RDBE: 9.5

HO

O

O

NO2

N

C23H21N2O5+, 405.1445

Nitrogen rule: Even, RDBE: 14.5

HO

Figure17: Mass fragmentation pathway of CD1

Page 21: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-21

Figure18:High resolution mass Spectrum of CD2

Page 22: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-22

Figure19:Mass accuracy of CD2

Page 23: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-23

Figure20:High resolution MSMS Spectrum of CD2

Page 24: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-24

Figure21: MSn spectrum of CD2 (a)

Page 25: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-25

Figure 22: MSn spectrum of CD2 (b)

Page 26: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-26

C27H31N2O10+, 543.1973

Nitrogen rule: Even, RDBE: 13.5CD2

O O

O

O

O

O

O

NO2

NH2 OH

C9H9+, 117.0699

Nitrogen rule: Even, RDBE: 5.5

C26H31N2O8+, 499.2075

Nitrogen rule: Even, RDBE: 12.5

O O

O

O

O

NO2

NH2 OH

-CO2

C26H29N2O6+, 465.2020

Nitrogen rule: Even, RDBE: 13.5

HO

O

O

NO2

N

OH

-H 2O2

C23H21N2O5+, 405.1445

Nitrogen rule: Even, RDBE: 14.5

O

O

NO2

N

OH

-C3H10O3

O O

O

O

NH2

OH

C18H22NO5+, 332.1492

Nitrogen rule: Odd, RDBE: 8.5

-C9H9NO5

O

C9H9O+, 133.0648Nitrogen rule: Even, RDBE: 5.5

-C9H13NO4

C8H9+, 105.0699

Nitrogen rule: Even, RDBE: 4.5

-CO

-C18H22N2O10

C27H29N2O9+, 525.1868

Nitrogen rule: Even, RDBE: 14.5

O O

O

O

O

O

O

NO2

NH2

-H2O

C26H29N2O7+, 481.1969

Nitrogen rule: Even, RDBE: 13.5

O O

O

O

O

NO2

NH2

-CO2

C18H19N2O7+, 375.1187

Nitrogen rule: Even, RDBE: 10.5

H2O

O

O

O

O

NO2

N

-C9H10O2

O

NO2

N

C14H11N2O4+, 271.0713

Nitrogen rule: Even, RDBE: 10.5

HO

-C4H8O3

C26H27N2O8+, 495.1762

Nitrogen rule: Even, RDBE: 14.5

O O

O

O

O

O

NO2

NH2

-CH2O

C15H12NO6+, 302.0659

Nitrogen rule: Odd, RDBE: 10.5

O O

O

O OH

O

NH2

-C11H15NO2

C13H10NO4+, 244.0604

Nitrogen rule: Odd, RDBE: 9.5

O O

OH

O

NH2

-C2H2O2

NH2

O

OO

C10H18NO3+, 200.1281

Nitrogen rule: Odd, RDBE: 2.5

-C17H11NO6

NH2

OO

C7H12NO2+, 142.0863

Nitrogen rule: Odd, RDBE: 2.5

-C3H6O

C18H23N2O10+, 427.1347

Nitrogen rule: Even, RDBE: 8.5

O O

HO

O

O

O

O

NO2

NH2 OH -C9H8

Figure 23: Mass fragmentation pathway of CD2

Page 27: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-27

Figure24:High resolution mass Spectrum of CD3

Page 28: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-28

Figure 25: Mass accuracy of CD3

Page 29: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-29

Figure26:High resolution MSMS Spectrum of CD3

Page 30: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-30

Figure27: MSn spectrum of CD3

Page 31: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-31

-C3H6O

Figure28: Mass fragmentation pathway of CD3

Page 32: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-32

Figure29:High resolution mass Spectrum of KD1

Page 33: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-33

Figure30: Mass accuracy of KD1

Page 34: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-34

Figure31: GCMS spectrum of KD2

Page 35: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-35

Figure32: GCMS Library match spectrum for KD2

Page 36: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-36

Figure 33:High resolution mass Spectrum of KD3

Page 37: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-37

Figure 34: Mass accuracy of KD3

Page 38: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-38

Figure 35:High resolution mass Spectrum of KD4

Page 39: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-39

Figure36: Mass accuracy of KD4

Page 40: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-40

Figure37: 1H NMR Spectrum of CD1 (500 MHz, DMSO-d6, 298K)

Page 41: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-41

Figure38:13C NMR Spectrum of CD1 (126 MHz, DMSO-d6, 298K)

Page 42: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-42

Figure39:DEPT90 NMR Spectrum of CD1 (126 MHz, DMSO-d6, 298K)

Page 43: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-43

Figure 40: DEPT135 NMR Spectrum of CD1 (126 MHz, DMSO-d6, 298K)

Page 44: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-44

Figure 41: COSY NMR Spectrum of CD1 (500 MHz, DMSO-d6, 298K)

Page 45: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-45

Figure 42: TOCSY NMR Spectrum of CD1 (500 MHz, DMSO-d6, 298K)

Page 46: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-46

Figure 43: HSQC NMR Spectrum of CD1 (500 MHz, DMSO-d6, 298K)

Page 47: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-47

Figure 44: HMBC NMR Spectrum of CD1 (500 MHz, DMSO-d6, 298K)

Page 48: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-48

Figure45: NOESY NMR Spectrum of CD1 (500 MHz, DMSO-d6, 298K)

Page 49: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-49

Figure46:ROESYNMR Spectrum of CD1 (500 MHz, DMSO-d6, 298K)

Page 50: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-50

Figure47: ROESY NMR Zoomed Spectrum of CD1 (500 MHz, DMSO-d6, 298K)

Page 51: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-51

Figure48: 1H NMR Spectrum of CD2 (500 MHz, DMSO-d6, 298K)

Page 52: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-52

Figure49:13C NMR Spectrum of CD2 (126 MHz, DMSO-d6, 298K)

Page 53: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-53

Figure 50:DEPT90 NMR Spectrum of CD2 (126 MHz, DMSO-d6, 298K)

Page 54: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-54

Figure 51:DEPT135 NMR Spectrum of CD2 (126 MHz, DMSO-d6, 298K)

Page 55: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-55

Figure 52: COSY NMR Spectrum of CD2 (500 MHz, DMSO-d6, 298K)

Page 56: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-56

Figure 53: TOCSY NMR Spectrum of CD2 (500 MHz, DMSO-d6, 298K)

Page 57: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-57

Figure 54: HSQC NMR Spectrum of CD2 (500 MHz, DMSO-d6, 298K)

Page 58: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-58

Figure55: HMBC NMR Spectrum of CD2 (500 MHz, DMSO-d6, 298K)

Page 59: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-59

Figure56: NOESY NMR Spectrum of CD2 (500 MHz, DMSO-d6, 298K)

Page 60: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-60

Figure57:ROESYNMR Spectrum of CD2 (500 MHz, DMSO-d6, 298K)

Page 61: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-61

Figure58: ROESY NMR Zoomed Spectrum of CD2 (500 MHz, DMSO-d6, 298K)

Page 62: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-62

Figure59: 1H NMR Spectrum of CIL (500 MHz, DMSO-d6, 298K)

Page 63: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-63

Figure60:13C NMR Spectrum of CIL (126 MHz, DMSO-d6, 298K)

Page 64: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-64

Figure61:DEPT90 NMR Spectrum of CIL (126 MHz, DMSO-d6, 298K)

Page 65: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-65

Figure62:DEPT135 NMR Spectrum of CIL (126 MHz, DMSO-d6, 298K)

Page 66: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-66

Figure63: COSY NMR Spectrum of CIL (500 MHz, DMSO-d6, 298K)

Page 67: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-67

Figure64: TOCSY NMR Spectrum of CIL(500 MHz, DMSO-d6, 298K)

Page 68: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-68

Figure65: HSQC NMR Spectrum of CIL(500 MHz, DMSO-d6, 298K)

Page 69: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-69

Figure66: HMBC NMR Spectrum of CIL(500 MHz, DMSO-d6, 298 K)

Page 70: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-70

Figure67: NOESY NMR Spectrum of CIL(500 MHz, DMSO-d6, 298K)

Page 71: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-71

Figure68: 1H NMR Spectrum of CD3 (500 MHz, DMSO-d6, 298K)

Page 72: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-72

Figure69:13C NMR Spectrum of CD3 (126 MHz, DMSO-d6, 298K)

Page 73: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-73

Figure70:DEPT90 NMR Spectrum of CD3 (126 MHz, DMSO-d6, 298K)

Page 74: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-74

Figure71:DEPT135 NMR Spectrum of CD3 (126 MHz, DMSO-d6, 298K)

Page 75: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-75

Figure72: COSY NMR Spectrum of CD3 (500 MHz, DMSO-d6, 298K)

Page 76: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-76

Figure73: TOCSY NMR Spectrum of CD3(500 MHz, DMSO-d6, 298K)

Page 77: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-77

Figure74: HSQC NMR Spectrum of CD3(500 MHz, DMSO-d6, 298K)

Page 78: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-78

Figure75: HMBC NMR Spectrum of CD3(500 MHz, DMSO-d6, 298 K)

Page 79: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-79

Figure76:IRSpectrumofCD1

Page 80: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-80

Figure77:IRSpectrumofCD2

Page 81: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-81

Figure78:IR Spectrum of CIL

Page 82: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-82

Figure 79: Prep HPLC chromatogram for the isolation of CD3.

Page 83: Isolation and characterization of novel degradation ... · S-1 Isolation and characterization of novel degradation products in Cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

S-83

Figure 80: Prep HPLC chromatogram for the isolation of CD1 and CD2.